Conclusions Trop-2 protein overexpression is significantly associated with higher tumor grade and serves as an independent prognostic factor for DFS in endometrioid endometrial cancer.

A new study by investigators from Mass General Brigham uncovers how a novel immunotherapy prevents squamous cell carcinoma, with benefits lasting five years after treatment. This therapy is the ...

The inclusion criteria for the patients were the following: i) diagnosis of endometrial adenocarcinoma, endometrioid in histology ... by us in epithelial ovarian cancer. [32] Briefly ...